chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: delayed reaction 3 days after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (delayed reaction 3 days after vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION COMPLICATION (delayed reaction 3 days after vaccine). At the time of the report, VACCINATION COMPLICATION (delayed reaction 3 days after vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Joint swelling, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Swelling of both my hands and feet; Swelling in the joints of both my hands; High temperature; Was achy; Low back pain; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet) and PERIPHERAL SWELLING (Swelling of both my hands and feet) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Was achy), BACK PAIN (Low back pain) and PYREXIA (High temperature). On 05-Mar-2021, the patient experienced RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet) and JOINT SWELLING (Swelling in the joints of both my hands). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet), JOINT SWELLING (Swelling in the joints of both my hands) and PYREXIA (High temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-059980 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Red, blotchy, & itchy rash on the tops of my hands, tops of my feet; Swelling of both my hands and feet; Swelling in the joints of both my hands; High temperature; Was achy; Low back pain; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet) and PERIPHERAL SWELLING (Swelling of both my hands and feet) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Was achy), BACK PAIN (Low back pain) and PYREXIA (High temperature). On 05-Mar-2021, the patient experienced RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet) and JOINT SWELLING (Swelling in the joints of both my hands). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, PAIN (Was achy), BACK PAIN (Low back pain), RASH PRURITIC (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), RASH ERYTHEMATOUS (Red, blotchy, & itchy rash on the tops of my hands, tops of my feet), PERIPHERAL SWELLING (Swelling of both my hands and feet), JOINT SWELLING (Swelling in the joints of both my hands) and PYREXIA (High temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-059980 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). The patient was treated with PENICILLIN NOS for Vertigo, at an unspecified dose and frequency. At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 04-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). The patient was treated with PENICILLIN NOS for Vertigo, at an unspecified dose and frequency. At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness all over her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRURITUS (Itchiness all over her body). At the time of the report, PRURITUS (Itchiness all over her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Rash around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE RASH (Rash around the injection site). At the time of the report, INJECTION SITE RASH (Rash around the injection site) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle spasms
Clinical narrative: muscle pull; sore in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included METHYLPREDNISOLONE, LOSARTAN, METOPROLOL, WARFARIN and ROSUVASTATIN for an unknown indication.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 06-Mar-2021, the patient experienced MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder). At the time of the report, MUSCLE SPASMS (muscle pull) and ARTHRALGIA (sore in shoulder) outcome was unknown.            Treatment details included Methylprednisolone.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia
Clinical narrative: flu like symptoms and side effects; every joint in her body ached like she couldn't describe; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms and side effects) and MYALGIA (every joint in her body ached like she couldn't describe) outcome was unknown.            Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: Swelling at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling at the site of injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INJECTION SITE SWELLING (Swelling at the site of injection). At the time of the report, INJECTION SITE SWELLING (Swelling at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and Concomitant medicines were not included  Action taken with mRNA-1273 in response to the event was unknown
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Warmth; Dizziness; Redness; Pain; Swelling; Headache; Fatigue; Chills; Fever (Temperature 102 to 104F); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included ASCORBIC ACID (VIT C), LISINOPRIL, CHLORTHALIDONE, CLOPIDOGREL, ASPIRIN [ACETYLSALICYLIC ACID], CETIRIZINE, METOPROLOL, ATORVASTATIN and MONTELUKAST for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain), VACCINATION SITE SWELLING (Swelling), HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 04-Mar-2021, HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 102 - 104f (High) Temperature 102 to 104F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warmth; Dizziness; Redness; Pain; Swelling; Headache; Fatigue; Chills; Fever (Temperature 102 to 104F); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included ASCORBIC ACID (VIT C), LISINOPRIL, CHLORTHALIDONE, CLOPIDOGREL, ASPIRIN [ACETYLSALICYLIC ACID], CETIRIZINE, METOPROLOL, ATORVASTATIN and MONTELUKAST for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain), VACCINATION SITE SWELLING (Swelling), HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 04-Mar-2021, HEADACHE (Headache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever (Temperature 102 to 104F)) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warmth), DIZZINESS (Dizziness), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Pain) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 102 - 104f (High) Temperature 102 to 104F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site inflammation, Injection site pain, Pruritus, Tenderness
Clinical narrative: Redness on her left arm, and other parts of her body; Itchiness on her left arm; Pain at the injection site; Tenderness at the injection site; Inflammation at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site). At the time of the report, ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.    Reporter did not allow further contact
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Nausea, Retching, Tremor
Clinical narrative: shaking all over; breathing really hard; nauseated; dry heaves; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     The patient's past medical history included Alzheimer's disease. Concomitant products included CLOPIDOGREL, GALANTAMINE and ROSUVASTATIN.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves). On 28-Feb-2021, TREMOR (shaking all over), DYSPNOEA (breathing really hard), NAUSEA (nauseated) and RETCHING (dry heaves) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.    Reporter did not allow further contact
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Hypertension, Pain in extremity, Pruritus
Clinical narrative: itching in her body, as if a mosquito was biting her in various parts of her body; itch, as if she has an allergy clothing; uncomfortable; little arm pain; chills; blood pressure goes up because she gets nervous; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included blood pressure amlodipine, hydrochlorothiazide Diuretic, aspirin per day and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain), CHILLS (chills) and HYPERTENSION (blood pressure goes up because she gets nervous). At the time of the report, PRURITUS (itching in her body, as if a mosquito was biting her in various parts of her body), PRURITUS (itch, as if she has an allergy clothing), DISCOMFORT (uncomfortable), PAIN IN EXTREMITY (little arm pain), CHILLS (chills) and HYPERTENSION (blood pressure goes up because she gets nervous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Rash erythematous, Vaccination site rash
Clinical narrative: Rash; Muscle soreness; Red patch; Red marks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks). At the time of the report, VACCINATION SITE RASH (Rash), MYALGIA (Muscle soreness), RASH ERYTHEMATOUS (Red patch) and ERYTHEMA (Red marks) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site swelling
Clinical narrative: still have swollen area at the injection site; slight headache; place where she gave me vaccine was swollen; A spontaneous report (United States) was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events slight headache, place where she gave me vaccine was swollen, still have swollen area at the injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Lot# 025A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Mar 2021, the patient experienced the event(s) slight headache. place where she gave me vaccine was swollen. On 5 Mar 2021, the patient experienced the event(s) still have swollen area at the injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), slight headache, place where she gave me vaccine was swollen,still have swollen area at the injection site was unknown.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching around belly; Rash around belly; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching around belly) and RASH (Rash around belly) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O24M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching around belly) and RASH (Rash around belly). At the time of the report, PRURITUS (Itching around belly) and RASH (Rash around belly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.    Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Feeling abnormal, Headache, Influenza like illness, Pyrexia
Clinical narrative: no appetite; flu like symptoms; feels like has been hit by a truck; Fever; terrific headache; Injection arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm pain). On 05-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache). At the time of the report, DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever), HEADACHE (terrific headache) and VACCINATION SITE PAIN (Injection arm pain) outcome was unknown.            Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: no appetite; flu like symptoms; feels like has been hit by a truck; Fever; terrific headache; Injection arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm pain). On 05-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache). At the time of the report, DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever), HEADACHE (terrific headache) and VACCINATION SITE PAIN (Injection arm pain) outcome was unknown.            Reporter did not allow further contact
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain in extremity
Clinical narrative: Dizziness; Sore Arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dyspnoea, Feeling hot, Headache
Clinical narrative: sick to her stomach; difficulty breathing; HOT; nauseous; everything hurt (muscle pain); headache; chills; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous) and MYALGIA (everything hurt (muscle pain)) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy NOS. Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: sick to her stomach; difficulty breathing; HOT; nauseous; everything hurt (muscle pain); headache; chills; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous) and MYALGIA (everything hurt (muscle pain)) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Allergy NOS. Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever). At the time of the report, ABDOMINAL DISCOMFORT (sick to her stomach), DYSPNOEA (difficulty breathing), FEELING HOT (HOT), NAUSEA (nauseous), MYALGIA (everything hurt (muscle pain)), HEADACHE (headache), CHILLS (chills) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: dark pink discoloration at the site of injection; heat at the site of injection; itchiness at the site of injection; slight pain at the site of injection; sense of slight fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LOSARTAN for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue). At the time of the report, VACCINATION SITE ERYTHEMA (dark pink discoloration at the site of injection), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE PAIN (slight pain at the site of injection) and FATIGUE (sense of slight fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Body ache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced MYALGIA (Body ache) and CHILLS (chills). At the time of the report, MYALGIA (Body ache) and CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were reported No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up information received on 21-Jul-2021 and included events outcome was updated from unknown to recovered.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Myalgia, Pollakiuria
Clinical narrative: flu like symptoms; peeing terribly; body aches; bad fatigue that she hardly get up; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METHOTREXATE, FOLIC ACID and AMLODIPINE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), POLLAKIURIA (peeing terribly), MYALGIA (body aches) and FATIGUE (bad fatigue that she hardly get up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Pain, Pyrexia, Vaccination site erythema
Clinical narrative: body aches; Covid arm; stomach ache; redness on arm; fever; pain in injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm) and PYREXIA (fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site reaction
Clinical narrative: body aches; Covid arm; stomach ache; redness on arm; fever; pain in injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm) and PYREXIA (fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (Covid arm), ABDOMINAL PAIN UPPER (stomach ache), VACCINATION SITE ERYTHEMA (redness on arm), PYREXIA (fever), VACCINATION SITE PAIN (pain in injection site) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oral herpes, Vaccination site pain
Clinical narrative: cold sore; sore arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (cold sore), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 05-Mar-2021, the patient experienced ORAL HERPES (cold sore), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue). At the time of the report, ORAL HERPES (cold sore) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Influenza like illness, Myalgia, Nausea
Clinical narrative: Arm Soreness; Flu-like symptoms; No energy; Nausea; Muscle Aches; Very bad fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea) and MYALGIA (Muscle Aches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue). At the time of the report, PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue) outcome was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm Soreness; Flu-like symptoms; No energy; Nausea; Muscle Aches; Very bad fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea) and MYALGIA (Muscle Aches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue). At the time of the report, PAIN IN EXTREMITY (Arm Soreness), INFLUENZA LIKE ILLNESS (Flu-like symptoms), ASTHENIA (No energy), NAUSEA (Nausea), MYALGIA (Muscle Aches) and FATIGUE (Very bad fatigue) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity
Clinical narrative: sore arm; little bit nausea; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Asthma.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm), NAUSEA (little bit nausea) and FATIGUE (extreme fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.